Accessibility settings

This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, eHealth) (411) MRC funded proposals with peer-review reports (UK) (2)

Published on in Vol 6, No 9 (2017): September

Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial

Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial

Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial

Authors of this article:

Keira Annie Markey1, 2 Author Orcid Image ;   Ryan Ottridge3 Author Orcid Image ;   James L Mitchell1, 2 Author Orcid Image ;   Caroline Rick3 Author Orcid Image ;   Rebecca Woolley3 Author Orcid Image ;   Natalie Ives3 Author Orcid Image ;   Peter Nightingale4 Author Orcid Image ;   Alexandra J Sinclair1, 2 Author Orcid Image
Article Authors Cited by (37) Tweetations (10) Metrics

Altmetric

Altmetric discovers Social Media mentions. Click the ‘See more details’ link for a full report.

Dimensions

Dimensions discovers Citations. Click the ‘details’ link for a full report.

Metrics Since Publication

Download .csv
Daily | Monthly | Annually